Author Information
Jordi Clarimón is a prominent researcher specializing in the genetics of neurodegenerative disorders. He is affiliated with the Genetics of Neurodegenerative Disorders Unit at the Sant Pau Biomedical Research Institute, Hospital de la Santa Creu i Sant Pau, and the Universitat Autònoma de Barcelona, located in Barcelona, Spain. Additionally, he is part of CIBERNED, the Center for Networked Biomedical Research into Neurodegenerative Diseases in Madrid, Spain. His work primarily focuses on understanding the genetic factors contributing to diseases such as Alzheimer's, Parkinson's, and frontotemporal dementia.Research Contributions
Jordi Clarimón has made significant contributions to the field of genetics, particularly concerning neurodegenerative diseases. In 2022, he explored the association between smoking and the age at onset of Parkinson's disease. His research in 2021 included identifying rare damaging variants in genes ATB8B4 and ABCA1 as risk factors for Alzheimer's disease and examining the protective effects of HLA-DRB1*04 subtypes in Alzheimer’s and Parkinson's diseases. He has also investigated genetic variations as phenotype modifiers in frontotemporal dementia and used genome sequencing to uncover new loci associated with Lewy body dementia. His work is instrumental in deepening the understanding of the genetic architecture of these complex disorders.Aliases
Jordi Clarimón is known by several aliases, which include J. Clarimón, J Clarimón, and Jordi Clarimon. These variations in his name are used across different publications and research databases.Publication and Citation Metrics
| Metric |
Value |
| Citation Count |
18,268 |
| H-index |
57 |
| Paper Count |
303 |
